Lakefront Biotherapeutics (LKFT) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 2 121 sessions, May 8, 2026 to October 29, 2026
- Largest daily move
- +6.8% close of August 11, 2026
- 1-month change
- +9.5% closing prices, September 29, 2026 to October 29, 2026
Company Description
Lakefront Biotherapeutics (NASDAQ: LKFT) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.1B.
LKFT has gained 9.5% over the past month. The last closing price was $32.33.
For FY2025, Lakefront Biotherapeutics reported revenue of $1.3B with net income of $376.6M and diluted earnings per share of $5.72. The company operates at a net profit margin of 28.8%.
This page collects what Stock Titan holds for LKFT, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Lakefront Biotherapeutics (LKFT) closed at $32.33 on October 29, 2026. Over the past month, the price has gained 9.5%.
LKFT Metrics & Rankings
Price returns through October 29, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Lakefront Biotherapeutics has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all LKFT news →
SEC Filings
Lakefront Biotherapeutics has filed 10 recent SEC filings, including 10 Form 6-K. The most recent filing was submitted on October 20, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LKFT SEC filings →
Financial Highlights
Lakefront Biotherapeutics generated $1.3B in revenue in FY2025, retaining a 97.3% gross margin, operating income reached $346.3M (26.5% operating margin), and net income was $376.6M, reflecting a 28.8% net profit margin. Diluted earnings per share stood at $5.72. The company generated -$302.2M in operating cash flow. The current ratio was 20.15, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Lakefront Biotherapeutics (LKFT) currently stands at 3.3 million shares, down 2.8% from the previous reporting period, representing 6.8% of the float. Since May 2026, short interest has increased by 107.0%.
Days to Cover History
Days to cover for Lakefront Biotherapeutics (LKFT) currently stands at 9.5 days, down 23.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 9.4 to 16.1 days.
LKFT Company Profile & Sector Positioning
Lakefront Biotherapeutics (LKFT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.